索尔塔酶的结构和功能见解以及它们与抗病毒性化合物的相互作用
Sowmiya Sri Sivaramalingam1, Deepsikha Jothivel1, Deenadayalan Karaiyagowder Govindarajan1,2
1Research Center for Excellence in Microscopy, Department of Biotechnology, Kumaraguru College of Technology, Coimbatore, 641049, Tamil Nadu, India.
Current research in structural biology
|July 11, 2024
概括
排序酶定细菌表面蛋白质,对于病原体的毒性至关重要. 本综述探讨了索尔塔酶结构,它们的蛋白质基质和抑制剂,以开发新的抗菌战略.
科学领域:
- 微生物学 微生物学
- 结构生物学 结构生物学
- 药物发现 药物发现 药物发现
背景情况:
- 排序酶蛋白是格拉姆阳性细菌中必不可少的膜蛋白.
- 它们通过细胞壁分类 (CWS) 基因对表面蛋白质进行定,这对柱子组装和毒性至关重要.
- 索尔塔酶及其基质是关键的毒性因素,使它们成为抗微生物药物的目标.
研究的目的:
- 提供关于索尔塔酶和皮林蛋白结构的全面审查.
- 检查类酶及其抑制剂之间的分子相互作用.
- 增强对索尔塔酶介导的柱子组合的理解,并确定抗微生物策略.
主要方法:
- 对有关索尔塔酶和皮林蛋白结构的现有文献的综述.
- 分析结构和功能数据关于类酶抑制剂相互作用的分析.
- 综合有关索尔塔酶通路和毒性机制的信息.
主要成果:
- 详细讨论不同类型酶类和皮林基质的结构特征.
- 从结构和功能角度研究类酶和抑制剂之间的分子相互作用.
- 确定针对排序途径的当前策略.
结论:
- 排序酶介导的定和柱子组合对于细菌毒性至关重要.
- 了解类酶抑制剂相互作用是开发新型抗微生物疗法的关键.
- 准排序酶通路提供了一种有前途的方法来对抗格拉姆阳性细菌感染.
相关概念视频
Structure-Activity Relationships and Drug Design
697
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
697
Viral Structure
62.1K
Viruses are extraordinarily diverse in shape and size, but they all have several structural features in common. All viruses have a core that contains a DNA- or RNA-based genome. The core is surrounded by a protective coat of proteins called the capsid. The capsid is composed of subunits called capsomeres. The capsid and genome-containing core are together known as the nucleocapsid.
62.1K
Combined Effects of Drugs: Synergism
3.8K
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
Such synergistic combinations...
3.8K
Ligand Binding and Linkage
4.8K
Allosteric proteins have more than one ligand binding site; the binding of a ligand to any of these sites influences the binding of ligands to the other sites. When a protein is allosteric, its binding sites are called coupled or linked. In the case of enzymes, the site that binds to the substrate is known as the active site and the other site is known as the regulatory site. When a ligand binds to the regulatory site, this leads to conformational changes in the protein that can influence...
4.8K
Antimicrobial Proteins
974
Antimicrobial proteins are important components of the immune system. They aid the body in combating pathogens by either killing them directly or hindering their replication processes. Four main types of antimicrobial substances are interferons, the complement system, iron-binding proteins, and antimicrobial proteins.
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...
974
Allosteric Proteins-ATCase
5.7K
Binding sites linkages can regulate a protein's function. For example, enzyme activity is often regulated through a feedback mechanism where the end product of the biochemical process serves as an inhibitor.
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis...
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis...
5.7K


